Effect of Hip-focused Neuromuscular Activation Exercise on Foot Posture and Neuromuscular Control
A Cross-over Study to Investigate the Effect of Hip-focused Neuromuscular Activation Exercise on Foot Posture and Neuromuscular Control
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Elif Turgut, PhD
- Phone Number: 00903123051576
- Email: elifcamci@hacettepe.edu.tr
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- To be included, participants should be between the ages of 18 and 45 years.
Exclusion Criteria:
- Participants will be excluded from this study if they have a history of lower body trauma or surgery, or positive trendelenburg sign and slump test.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control
No intervention
|
|
|
Experimental: Neuromuscular Exercise
|
Hip focused Neuromuscular Activation Exercise
|
|
Sham Comparator: Sham Exercise
|
Hip focused Neuromuscular Activation Exercise
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Navicular Drop Test
Time Frame: 1 year
|
Navicular Drop Test
|
1 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Star Excursion Y-Balance Test
Time Frame: 1 year
|
Star Excursion Y-Balance Test
|
1 year
|
|
Frontal Plane Projection Angle
Time Frame: 1 year
|
Frontal Plane Projection Angle
|
1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Elif Turgut, PhD, Hacettepe University
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- GO16542
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.